These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28628947)

  • 1. Meta-analysis of determinants of survival following treatment of recurrent hepatocellular carcinoma.
    Erridge S; Pucher PH; Markar SR; Malietzis G; Athanasiou T; Darzi A; Sodergren MH; Jiao LR
    Br J Surg; 2017 Oct; 104(11):1433-1442. PubMed ID: 28628947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: comparative effectiveness of treatment modalities.
    Ho CM; Lee PH; Shau WY; Ho MC; Wu YM; Hu RH
    Surgery; 2012 May; 151(5):700-9. PubMed ID: 22284764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
    Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
    Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early intrahepatic recurrence of hepatocellular carcinoma after hepatectomy treated with re-hepatectomy, ablation or chemoembolization: a prospective cohort study.
    Wang K; Liu G; Li J; Yan Z; Xia Y; Wan X; Ji Y; Lau WY; Wu M; Shen F
    Eur J Surg Oncol; 2015 Feb; 41(2):236-42. PubMed ID: 25434327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent hepatocellular carcinoma: a Western strategy that emphasizes the impact of pathologic profile of the first resection.
    Meniconi RL; Komatsu S; Perdigao F; Boëlle PY; Soubrane O; Scatton O
    Surgery; 2015 Mar; 157(3):454-62. PubMed ID: 25633732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of treatment modalities on patients with single nodular recurrence of hepatocellular carcinoma.
    Ueno M; Uchiyama K; Ozawa S; Nakase T; Togo N; Hayami S; Yamaue H
    Surg Today; 2009; 39(8):675-81. PubMed ID: 19639434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing trends in long-term outcomes after hepatic resection for hepatocellular carcinoma: A 30-year, single-center experience.
    Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    Anticancer Res; 2013 Nov; 33(11):5097-105. PubMed ID: 24222155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic Re-resection Versus Transarterial Chemoembolization for the Treatment of Recurrent Hepatocellular Carcinoma after Initial Resection: a Systematic Review and Meta-analysis.
    Wang DY; Liu L; Qi XS; Su CP; Chen X; Liu X; Chen J; Li HY; Guo XZ
    Asian Pac J Cancer Prev; 2015; 16(13):5573-8. PubMed ID: 26225712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoembolization of recurrent hepatoma after curative resection: prognostic factors.
    Zu QQ; Liu S; Zhou CG; Yang ZQ; Xia JG; Zhao LB; Shi HB
    AJR Am J Roentgenol; 2015 Jun; 204(6):1322-8. PubMed ID: 26001244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern.
    Zhang X; Li C; Wen T; Yan L; Li B; Yang J; Wang W; Xu M; Lu W; Jiang L
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):933-40. PubMed ID: 25933127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized clinical trial of chemoembolization plus radiofrequency ablation versus partial hepatectomy for hepatocellular carcinoma within the Milan criteria.
    Liu H; Wang ZG; Fu SY; Li AJ; Pan ZY; Zhou WP; Lau WY; Wu MC
    Br J Surg; 2016 Mar; 103(4):348-56. PubMed ID: 26780107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
    Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
    J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of hepatocellular carcinoma: an overview of major findings from meta-analyses.
    Qi X; Zhao Y; Li H; Guo X; Han G
    Oncotarget; 2016 Jun; 7(23):34703-51. PubMed ID: 27167195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
    Shim JH; Kim KM; Lee YJ; Ko GY; Yoon HK; Sung KB; Park KM; Lee SG; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    Ann Surg Oncol; 2010 Mar; 17(3):869-77. PubMed ID: 20033326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-disciplinary Concurrent Management of Recurrent Hepatocellular Therapy is Superior to Sequential Therapy.
    Fields TD; Philips P; Scoggins CR; Tatum C; Kelly L; McMasters KM; Martin RCG
    World J Surg; 2017 May; 41(5):1331-1339. PubMed ID: 27905019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of surgical microwave ablation for recurrent hepatocellular carcinoma after curative hepatectomy.
    Ryu T; Takami Y; Wada Y; Hara T; Sasaki S; Saitsu H
    HPB (Oxford); 2020 Mar; 22(3):461-469. PubMed ID: 31473076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial.
    Peng ZW; Zhang YJ; Liang HH; Lin XJ; Guo RP; Chen MS
    Radiology; 2012 Feb; 262(2):689-700. PubMed ID: 22157201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.
    Minagawa M; Makuuchi M; Takayama T; Kokudo N
    Ann Surg; 2003 Nov; 238(5):703-10. PubMed ID: 14578733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of radiofrequency ablation compared with transarterial chemoembolization for the treatment of recurrent hepatocellular carcinoma: a comparative survival analysis.
    Koh PS; Chan AC; Cheung TT; Chok KS; Dai WC; Poon RT; Lo CM
    HPB (Oxford); 2016 Jan; 18(1):72-8. PubMed ID: 26776854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.